SCHEMBL12358709

SCHEMBL12358709

NS(=O)(=O)c1ccccc1-c1ccc2[nH]c(-c3ccccc3)nc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 7/20 0.54
▸ SCD O00767 2/20 0.50
▸ CHEK2 O96017 4/20 0.48
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ GAA P10253 2/20 0.48
▸ NPBWR1 P48145 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ TNKS O95271 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ GFER P55789 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ GLA P06280 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ RCE1 Q9Y256 1/20 0.45
▸ TP53 P04637 1/20 0.43
▸ POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12358815 0.91 CHEK2 (0.49) TRPV1SCDCHEK2NPC1RAB9A
SCHEMBL12358843 0.89 SCD (0.54) TRPV1SCDCHEK2NPC1RAB9A
SCHEMBL12364806 0.88 IDO1 (0.50) TRPV1SCDNPC1RAB9AGAA
SCHEMBL12359213 0.88 TRPV1 (0.60) TRPV1SCDCHEK2NPBWR1HDAC6
SCHEMBL12359198 0.86 TRPV1 (0.61) TRPV1SCDCHEK2
SCHEMBL12358817 0.86 HDAC6 (0.48) TRPV1SCDCHEK2NPC1RAB9A
SCHEMBL12359206 0.85 TRPV1 (0.62) TRPV1SCDCHEK2
SCHEMBL12358701 0.85 TRPV1 (0.52) TRPV1SCDNPBWR1
SCHEMBL12358864 0.84 TRPV1 (0.46) TRPV1SCDCHEK2NPC1RAB9A
SCHEMBL12359268 0.83 TRPV1 (0.48) TRPV1SCDCHEK2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110190344-A1 BENZIMIDAZOLE MODULATORS OF VR1 JANSSEN PHARMACEUTICA N.V. (BE) 2011-08-04 — — US disclosed
US-7951829-B2 Benzimidazole modulators of VR1 JANSSEN PHARMACEUTICA NV (BE) 2011-05-31 — — US disclosed
US-20070259936-A1 Benzimidazole Modulators of VR1 JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259936-A1 Benzimidazole Modulators of VR1 VRK1, VRK2, VIL1 TRPV1 29/4885SCD 4754/4885CHEK2 3484/4885
US-20110190344-A1 BENZIMIDAZOLE MODULATORS OF VR1 VRK1, VRK2, VIL1 TRPV1 29/4885SCD 4754/4885CHEK2 3484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback